From: Efficacy, safety, and tolerability of dolutegravir-based ART regimen in Durban, South Africa: a cohort study
Weight change from baseline
Frequency
Proportion (%)
No change
1 − 5% increase
6 − 10% increase
> 10% increase
1 − 5% decrease
6 − 10% decrease
> 10% decrease
55
137
73
48
74
33
5
12.9
32.2
17.2
11.3
17.4
7.8
1.2